Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Bevacizumab + FOLFIRI & Colorectal cancer (CRC), Bevacizumab + FOLFIRI is an accepted, on‑label regimen for metastatic Colorectal cancer (CRC) in both FDA and EMA frameworks as part of bevacizumab’s indication with irinotecan‑based fluoropyrimidine chemotherapy.
see also:
Angiogenesis inhibitors + Chemotherapy (CT) & Colorectal cancer (CRC)
Colorectal cancer (CRC) & Drugs/Treatments
…